Clinical Trials
60 trialsIMMUNO-SUP
Institut Paoli-Calmettes
Comparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical Prostatectomy
The First Affiliated Hospital of Zhengzhou University
UROVISIO
Lille Catholic University
MOST-D
Heinrich-Heine University, Duesseldorf
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Lipac Oncology LLC
Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Meteor 1
GlaxoSmithKline
Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer
M.D. Anderson Cancer Center
Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients
Astellas Pharma Inc
REMEDY
University Health Network, Toronto
EV-201
Astellas Pharma Inc
PAPRAC
Insel Gruppe AG, University Hospital Bern
BANN
University Medical Center Groningen
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
Hoffmann-La Roche
JAVELIN Bladder 100
Pfizer
MiMe-A
Jules Bordet Institute
flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer
National Cancer Institute (NCI)
Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer
National Cancer Institute (NCI)
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
National Cancer Institute (NCI)
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
NanOlogy, LLC
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer
Icahn School of Medicine at Mount Sinai
IP5-MATTER
Imperial College London
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical Cystectomy
University Hospital, Ghent
Oral Supplementation to Enhance Recovery Pilot Study
M.D. Anderson Cancer Center
Pre-Operative Single Shot Rectus Sheath Block
University of Alberta
MULTI
Hospices Civils de Lyon
STTELS
Seoul National University Bundang Hospital
Preoperative Guided Imagery in Patients Undergoing Urologic Surgery
University of California, San Francisco
Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy
Exosome Diagnostics, Inc.
LPN in Patients With High-complex Renal Tumors
Samsun Liv Hospital
YODO
AstraZeneca
Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy
Université de Sousse
Neuromuscular Blockade on Shoulder Pain of Elderly
M.D. Anderson Cancer Center
LUX-Bladder 1
Boehringer Ingelheim
Investigation of Sugammadex in Outpatient Urological Procedures
M.D. Anderson Cancer Center
Laparoscopic Partial Nephrectomy for cT1 Tumors
Samsun Liv Hospital
ChemoRenCan
University Hospital, Bordeaux
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
Stanford University
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
Chinese University of Hong Kong
Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study
Oslo University Hospital
OPTIMA
UroGen Pharma Ltd.
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients
UroGen Pharma Ltd.
Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection
H. Lee Moffitt Cancer Center and Research Institute
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
Fox Chase Cancer Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Achieve Life Sciences
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients
UroGen Pharma Ltd.
JASINT1
Pierre Fabre Medicament